ghk-cu latest research 2025 study november Ever heard of peptide? It's a naturally occurring copper peptide that GHK-Cu FDA Status and Compounding

Dihexa also stimulates hippocampal spinogenesis and synaptogenesis equivalent with HGF

Think of it like watering a plant

Look at what semaglutide, tirzepatide, and retatrutide all peptides are doing for people who have spent their whole lives suffering with obesity

Research-grade vials from reputable peptide suppliers meeting those same COA benchmarks are the next-best option when compounding access is unavailable

Read review Dihexa for Autism Spectrum Disorder (ASD) The Campbell rs1858830 MET promoter C-allele autism finding (the strongest mechanistic anchor to Dihexa pharmacology), the January 2026 mGluR5 PET 16-23% lower availability, the December 2025 DAYBUE STIX (trofinetide) Rett approval, the March 2026 FDA leucovorin decision (CFD only, not autism), the 270,701 NHS open referrals breaching NICE NG142, and the ~700,000 UK autistic population